| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An imaginary pandemic and its consequences
|
Bagcchi, Sanjeet
|
|
|
21 |
9 |
p. *
|
artikel
|
| 2 |
Barriers and enablers to implementing tuberculosis control strategies in EU and European Economic Area countries: a systematic review
|
Conroy, Olivia
|
|
|
21 |
9 |
p. e272-e280
|
artikel
|
| 3 |
Bell's palsy and SARS-CoV-2 vaccines—an unfolding story
|
Cirillo, Nicola
|
|
|
21 |
9 |
p. 1210-1211
|
artikel
|
| 4 |
Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
|
Ozonoff, Al
|
|
|
21 |
9 |
p. 1211-1212
|
artikel
|
| 5 |
Beyond COVID-19—will self-sampling and testing become the norm?
|
Boum, Yap
|
|
|
21 |
9 |
p. 1194-1195
|
artikel
|
| 6 |
Correction to Lancet Infect Dis 2021; 21: 858–67
|
|
|
|
21 |
9 |
p. e258
|
artikel
|
| 7 |
COVID-19 vaccine equity and booster doses
|
The Lancet Infectious Diseases,
|
|
|
21 |
9 |
p. 1193
|
artikel
|
| 8 |
Cryptococcal meningoencephalitis: time for action
|
Stott, Katharine Elizabeth
|
|
|
21 |
9 |
p. e259-e271
|
artikel
|
| 9 |
Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis
|
Tsang, Nicole Ngai Yung
|
|
|
21 |
9 |
p. 1233-1245
|
artikel
|
| 10 |
ECCMID 2021
|
Kazi, Farooq
|
|
|
21 |
9 |
p. 1216
|
artikel
|
| 11 |
Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial
|
François, Bruno
|
|
|
21 |
9 |
p. 1313-1323
|
artikel
|
| 12 |
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
|
Frampton, Dan
|
|
|
21 |
9 |
p. 1246-1256
|
artikel
|
| 13 |
Genomic-informed pathogen surveillance in Africa: opportunities and challenges
|
Inzaule, Seth C
|
|
|
21 |
9 |
p. e281-e289
|
artikel
|
| 14 |
Herpetic oesophagitis in an immunocompetent infant with gastroesophageal reflux
|
Peeters, Esther J E
|
|
|
21 |
9 |
p. 1332
|
artikel
|
| 15 |
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
|
Tenbusch, Matthias
|
|
|
21 |
9 |
p. 1212-1213
|
artikel
|
| 16 |
Images of a world facing a pandemic
|
De Ambrogi, Marco
|
|
|
21 |
9 |
p. 1225-1229
|
artikel
|
| 17 |
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
|
Vesikari, Timo
|
|
|
21 |
9 |
p. 1271-1281
|
artikel
|
| 18 |
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance
|
Mackenzie, Grant A
|
|
|
21 |
9 |
p. 1293-1302
|
artikel
|
| 19 |
Implementation strategies for passive respiratory syncytial virus immunisation
|
Sande, Charles J
|
|
|
21 |
9 |
p. 1200-1201
|
artikel
|
| 20 |
Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity
|
Spinelli, Matthew A
|
|
|
21 |
9 |
p. e296-e301
|
artikel
|
| 21 |
Increasing clindamycin resistance in group A streptococcus
|
White, Bryan P
|
|
|
21 |
9 |
p. 1208-1209
|
artikel
|
| 22 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
21 |
9 |
p. 1221
|
artikel
|
| 23 |
Is ceftriaxone similarly effective to benzylpenicillin in neurosyphilis?
|
Ke, Wujian
|
|
|
21 |
9 |
p. 1207
|
artikel
|
| 24 |
Is ceftriaxone similarly effective to benzylpenicillin in neurosyphilis? – Authors' reply
|
Bettuzzi, Thomas
|
|
|
21 |
9 |
p. 1207-1208
|
artikel
|
| 25 |
Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes
|
Ong, Sean Wei Xiang
|
|
|
21 |
9 |
p. 1195-1197
|
artikel
|
| 26 |
Lessons about COVID-19 vaccine hesitancy among minority ethnic people in the UK
|
Kadambari, Seilesh
|
|
|
21 |
9 |
p. 1204-1206
|
artikel
|
| 27 |
Malaria vaccine development—where are we?
|
Venkatesan, Priya
|
|
|
21 |
9 |
p. 1218
|
artikel
|
| 28 |
Marta Lado—Ebola, HIV, sexual health and more
|
Kirby, Tony
|
|
|
21 |
9 |
p. 1224
|
artikel
|
| 29 |
Memorialising Trump's pandemic (non-)response
|
Balakrishnan, Vijay Shankar
|
|
|
21 |
9 |
p. 1231
|
artikel
|
| 30 |
Monoclonal antibodies as antibacterial therapies: thinking outside of the box
|
Kollef, Marin H
|
|
|
21 |
9 |
p. 1201-1202
|
artikel
|
| 31 |
Negative antigen RDT and RT-PCR results do not rule out COVID-19 if clinical suspicion is strong
|
Lekpa, Fernando Kemta
|
|
|
21 |
9 |
p. 1209
|
artikel
|
| 32 |
Negative antigen RDT and RT-PCR results do not rule out COVID-19 if clinical suspicion is strong – Authors' reply
|
Mandeng, Nadia
|
|
|
21 |
9 |
p. 1210
|
artikel
|
| 33 |
Purnell Choppin
|
Bagcchi, Sanjeet
|
|
|
21 |
9 |
p. 1223
|
artikel
|
| 34 |
Research in brief
|
Devi, Sharmila
|
|
|
21 |
9 |
p. 1222
|
artikel
|
| 35 |
Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study
|
Li, You
|
|
|
21 |
9 |
p. 1303-1312
|
artikel
|
| 36 |
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial
|
Han, Htay-Htay
|
|
|
21 |
9 |
p. 1282-1292
|
artikel
|
| 37 |
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
|
Goepfert, Paul A
|
|
|
21 |
9 |
p. 1257-1270
|
artikel
|
| 38 |
Scaling up COVID-19 rapid antigen tests: promises and challenges
|
Peeling, Rosanna W
|
|
|
21 |
9 |
p. e290-e295
|
artikel
|
| 39 |
The long road to polio eradication
|
Balakrishnan, Vijay Shankar
|
|
|
21 |
9 |
p. 1217
|
artikel
|
| 40 |
The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out
|
Giles, Benjamin
|
|
|
21 |
9 |
p. 1213-1214
|
artikel
|
| 41 |
The truth inside the comedy
|
McQuillan, Cahal
|
|
|
21 |
9 |
p. 1230
|
artikel
|
| 42 |
Three are better than one—increasing HBV seroprotection by a tri-antigenic vaccine
|
van Bömmel, Florian
|
|
|
21 |
9 |
p. 1197-1198
|
artikel
|
| 43 |
Travel notice issued as Venezuela faces health system crisis
|
Bagcchi, Sanjeet
|
|
|
21 |
9 |
p. 1219
|
artikel
|
| 44 |
Treponema pallidum detection in lesion and non-lesion sites in men who have sex with men with early syphilis: a prospective, cross-sectional study
|
Towns, Janet M
|
|
|
21 |
9 |
p. 1324-1331
|
artikel
|
| 45 |
Triumph in China as it is certified malaria-free by WHO
|
Burki, Talha
|
|
|
21 |
9 |
p. 1220-1221
|
artikel
|
| 46 |
Two-test or three-test strategy for routine asymptomatic testing during air travel?
|
Shahid, Mohammad
|
|
|
21 |
9 |
p. 1214-1215
|
artikel
|
| 47 |
Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic
|
Chen, Paul Z
|
|
|
21 |
9 |
p. 1203-1204
|
artikel
|
| 48 |
Zika vaccines: can we solve one problem without creating another one?
|
Castanha, Priscila M S
|
|
|
21 |
9 |
p. 1198-1200
|
artikel
|
Tijdschrift beschrijving